According to the Chile’s Cercal Group CEO Claudia Velasco, the possibility of attending an event like BioHabana 2024 is very gratifying, so I thank the business group BioCubaFarma for the invitation to learn about the development of the biopharmaceutical industry in Cuba. In order to establish alliances with Cuba, a nation that is currently undergoing a technological revolution in the field of research in the healthcare sector, is a valuable opportunity for Cercal Group, a firm based in Chile with branches in Uruguay, Mexico, Colombia and with more than 1,850 clients worldwide, she said.
No comments:
Post a Comment